<unk>  (INN) is a semisynthetic aminoglycoside antibiotic which was derived from kanamycin. It is primarily used for the treatment of infections caused by multi-resistant bacteria including methicillin-resistant Staphylococcus aureus (MRSA).<unk>  was originally synthesized from dibekacin in 1973 by Hamao Umezawa and collaborators. It has been registered and marketed in Japan since 1990 under the trade name Habekacin.<unk>  is no longer covered by patent and generic versions of the drug are also available under such trade names as Decontasin and Blubatosine.
Arbekacin
Sakacin
Darifenacin
Solifenacin
Simvastatin
Tofenacin
Fluvastatin
Revefenacin